Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1993 1
1994 1
1995 1
1997 4
1998 1
1999 2
2001 2
2002 3
2003 2
2004 1
2005 4
2006 4
2008 2
2009 3
2010 2
2011 3
2012 6
2013 7
2014 11
2015 6
2016 9
2017 7
2018 13
2019 6
2020 10
2021 11
2022 13
2023 15
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
A global study for acute myeloid leukemia with RARG rearrangement.
Zhu HH, Qin YZ, Zhang ZL, Liu YJ, Wen LJ, You MJ, Zhang C, Such E, Luo H, Yuan HJ, Zhou HS, Liu HX, Xu R, Li J, Li JH, Hao JP, Jin J, Yu L, Zhang JY, Liu LP, Zhang LP, Huang RB, Shen SH, Gao SJ, Wang W, Yan XJ, Zhang XY, Du X, Chu XX, Yu YF, Wang Y, Mi YC, Lu Y, Cai Z, Su Z, Taussig DC, MacMahon S, Ball ED, Wang HY, Welch JS, Yin CC, Borthakur G, Sanz MA, Kantarjian HM, Huang JY, Hu J, Chen SN. Zhu HH, et al. Among authors: taussig dc. Blood Adv. 2023 Jul 11;7(13):2972-2982. doi: 10.1182/bloodadvances.2022008364. Blood Adv. 2023. PMID: 36799929 Free PMC article.
Molecular MRD status and outcome after transplantation in NPM1-mutated AML.
Dillon R, Hills R, Freeman S, Potter N, Jovanovic J, Ivey A, Kanda AS, Runglall M, Foot N, Valganon M, Khwaja A, Cavenagh J, Smith M, Ommen HB, Overgaard UM, Dennis M, Knapper S, Kaur H, Taussig D, Mehta P, Raj K, Novitzky-Basso I, Nikolousis E, Danby R, Krishnamurthy P, Hill K, Finnegan D, Alimam S, Hurst E, Johnson P, Khan A, Salim R, Craddock C, Spearing R, Gilkes A, Gale R, Burnett A, Russell NH, Grimwade D. Dillon R, et al. Among authors: taussig d. Blood. 2020 Feb 27;135(9):680-688. doi: 10.1182/blood.2019002959. Blood. 2020. PMID: 31932839 Free PMC article. Clinical Trial.
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML.
de Botton S, Fenaux P, Yee K, Récher C, Wei AH, Montesinos P, Taussig DC, Pigneux A, Braun T, Curti A, Grove C, Jonas BA, Khwaja A, Legrand O, Peterlin P, Arnan M, Blum W, Cilloni D, Hiwase DK, Jurcic JG, Krauter J, Thomas X, Watts JM, Yang J, Polyanskaya O, Brevard J, Sweeney J, Barrett E, Cortes J. de Botton S, et al. Among authors: taussig dc. Blood Adv. 2023 Jul 11;7(13):3117-3127. doi: 10.1182/bloodadvances.2022009411. Blood Adv. 2023. PMID: 36724515 Free PMC article.
Invasive EEG explorations.
Taussig D, Montavont A, Isnard J. Taussig D, et al. Neurophysiol Clin. 2015 Mar;45(1):113-9. doi: 10.1016/j.neucli.2014.11.006. Epub 2015 Jan 15. Neurophysiol Clin. 2015. PMID: 25703438 Review.
French guidelines on stereoelectroencephalography (SEEG).
Isnard J, Taussig D, Bartolomei F, Bourdillon P, Catenoix H, Chassoux F, Chipaux M, Clémenceau S, Colnat-Coulbois S, Denuelle M, Derrey S, Devaux B, Dorfmüller G, Gilard V, Guenot M, Job-Chapron AS, Landré E, Lebas A, Maillard L, McGonigal A, Minotti L, Montavont A, Navarro V, Nica A, Reyns N, Scholly J, Sol JC, Szurhaj W, Trebuchon A, Tyvaert L, Valenti-Hirsch MP, Valton L, Vignal JP, Sauleau P. Isnard J, et al. Among authors: taussig d. Neurophysiol Clin. 2018 Feb;48(1):5-13. doi: 10.1016/j.neucli.2017.11.005. Epub 2017 Dec 23. Neurophysiol Clin. 2018. PMID: 29277357 Review.
Indications and limits of stereoelectroencephalography (SEEG).
Minotti L, Montavont A, Scholly J, Tyvaert L, Taussig D. Minotti L, et al. Among authors: taussig d. Neurophysiol Clin. 2018 Feb;48(1):15-24. doi: 10.1016/j.neucli.2017.11.006. Epub 2018 Jan 17. Neurophysiol Clin. 2018. PMID: 29352627 Review.
When a virus lies in wait.
Taussig D, Wine Y. Taussig D, et al. Elife. 2021 Aug 4;10:e71121. doi: 10.7554/eLife.71121. Elife. 2021. PMID: 34347587 Free PMC article.
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML.
Othman J, Potter N, Mokretar K, Taussig D, Khan A, Krishnamurthy P, Latif AL, Cahalin P, Aries J, Amer M, Belsham E, Conneally E, Craddock C, Culligan D, Dennis M, Duncan C, Freeman SD, Furness C, Gilkes A, Gkreka P, Hodgson K, Ingram W, Jain M, King A, Knapper S, Kottaridis P, McMullin MF, Mohite U, Ngu L, O'Nions J, Patrick K, Rider T, Roberts W, Severinsen MT, Storrar N, Taylor T, Russell NH, Dillon R. Othman J, et al. Among authors: taussig d. Leukemia. 2023 Oct;37(10):2066-2072. doi: 10.1038/s41375-023-01994-x. Epub 2023 Aug 9. Leukemia. 2023. PMID: 37558736 Free PMC article.
Invasive evaluation in children (SEEG vs subdural grids).
Taussig D, Chipaux M, Fohlen M, Dorison N, Bekaert O, Ferrand-Sorbets S, Dorfmüller G. Taussig D, et al. Seizure. 2020 Apr;77:43-51. doi: 10.1016/j.seizure.2018.11.008. Epub 2018 Nov 16. Seizure. 2020. PMID: 30503504 Free article. Review.
137 results